Dr. Barry Dworkin

Moderna vs Pfizer antibody titre study cannot answer if it leads to differences in cellular immunity, protection against variants, duration, risks of transmission or clinical outcomes. Real world data shows they both work equally well. #vaccineswork

Medical Mythbusting Commentary for September 1, 2021

[display_podcast]

Source:
Moderna Makes Twice as Many Antibodies as Pfizer, Study Says

Reference:
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273

Related posts:

  1. NEJM study concludes that time required to determine Moderna’s effect on longevity of antibody, B and T cell response. However, the vaccine works. Worst-case scenario is that we will require a booster.
  2. NACI recommends second dose Pfizer/moderna vaccine for those who had AZ as their first dose.
  3. CDC and other regulators working to assess risk and if there is a causal relationship between mRNA vaccines and myo/pericarditis seen predominately in a small number of males 16-24 years old after 2nd dose.
  4. What should your #seconddose of #covidvaccine be if 1st was AZ? Factors include wait-time/availability, Delta variant prevalence, occupational risks, and study evidence. Answer seems to leaning to Pfizer or Moderna as 2nd dose of choice.